Thimiri Govindaraj, Deepak B2022-02-272022-02-272021-11Thimiri Govindaraj, D.B. 2021. Synthetic biology meets precision medicine: Drug repurposing for blood cancer precision medicine. <i>Hematology, Transfusion and Cell Therapy, 43(Suppl 3).</i> http://hdl.handle.net/10204/122952531-1379https://doi.org/10.1016/j.htct.2021.10.1022http://hdl.handle.net/10204/12295Optimizing Drug discovery and Translation is one of the key tracks in Global Challenges Annual meeting 2019 and is the critical factor in achieving UN Sustainable Development Goals 3 Good Health and Well Being. WHO reports Cancer is the second leading cause of death globally. The aim of the proposal is to establish robust drug screening platform which can identify drugs and drug combinations that are effective in precision medicine for relapsed individual South African Leukemia patients.FulltextenCancer cellsCancer drugsLeukemia patientsArticleThimiri Govindaraj, D. B. (2021). Synthetic biology meets precision medicine: Drug repurposing for blood cancer precision medicine. <i>Hematology, Transfusion and Cell Therapy, 43(Suppl 3)</i>, http://hdl.handle.net/10204/12295Thimiri Govindaraj, Deepak B "Synthetic biology meets precision medicine: Drug repurposing for blood cancer precision medicine." <i>Hematology, Transfusion and Cell Therapy, 43(Suppl 3)</i> (2021) http://hdl.handle.net/10204/12295Thimiri Govindaraj DB. Synthetic biology meets precision medicine: Drug repurposing for blood cancer precision medicine. Hematology, Transfusion and Cell Therapy, 43(Suppl 3). 2021; http://hdl.handle.net/10204/12295.TY - Article AU - Thimiri Govindaraj, Deepak B AB - Optimizing Drug discovery and Translation is one of the key tracks in Global Challenges Annual meeting 2019 and is the critical factor in achieving UN Sustainable Development Goals 3 Good Health and Well Being. WHO reports Cancer is the second leading cause of death globally. The aim of the proposal is to establish robust drug screening platform which can identify drugs and drug combinations that are effective in precision medicine for relapsed individual South African Leukemia patients. DA - 2021-11 DB - ResearchSpace DP - CSIR J1 - Hematology, Transfusion and Cell Therapy, 43(Suppl 3) KW - Cancer cells KW - Cancer drugs KW - Leukemia patients LK - https://researchspace.csir.co.za PY - 2021 SM - 2531-1379 T1 - Synthetic biology meets precision medicine: Drug repurposing for blood cancer precision medicine TI - Synthetic biology meets precision medicine: Drug repurposing for blood cancer precision medicine UR - http://hdl.handle.net/10204/12295 ER -25374